1200 Pharma utilizes medicinal chemistry technologies to streamline pre-clinical drug discovery processes and reduce clinical trial timelines. By enhancing the efficiency of drug development, the company addresses the lengthy and costly nature of bringing new therapeutics to market.

ByHeart produces an FDA-registered infant formula featuring a patented protein blend that closely mimics the composition of breast milk, utilizing organic, grass-fed whole milk for enhanced nutrient absorption and easier digestion. The formula addresses common infant feeding challenges by promoting softer stools, reduced spit-up, and improved weight gain, all backed by clinical research.

Figure develops Figure 03, a general-purpose humanoid robot designed for everyday household tasks. This robot utilizes the proprietary Helix AI system, enabling it to navigate and interact within unpredictable, ever-changing home environments. The platform aims to provide human-like assistance by performing chores in a manner consistent with human execution.

Finch Therapeutics develops microbiome-based therapeutics aimed at addressing serious unmet medical needs through insights gained from human microbiota transplantation studies. The company has established a robust intellectual property portfolio that supports a range of therapeutic applications in the microbiome field.

Lexense is a data-driven platform that streamlines access to the legal system by automating document preparation and communication among users and legal professionals. The platform utilizes predictive modeling to recommend effective legal strategies, enabling individuals and businesses to manage legal issues efficiently and pursue justice.

Ossio develops OSSIO _fiber_ ® implants, a bio-integrative material that mimics the natural minerals in bone, allowing for secure fixation and full integration into the body without leaving permanent hardware. This technology addresses the complications associated with traditional metal implants, such as removal surgeries and potential allergic reactions, by promoting natural bone healing and strength restoration.

Praxis Precision Medicines develops therapies for central nervous system disorders by utilizing genetic insights to address neuronal excitation-inhibition imbalances. The company focuses on delivering effective treatments for both rare and common conditions, aiming to improve patient outcomes through a patient-guided development approach.

Rad AI develops AI-driven software that automates the generation of radiology reports and impressions, allowing radiologists to dictate findings without the need for full sentence construction. This technology reduces report preparation time by over 60 minutes per shift and significantly decreases radiologist burnout by minimizing repetitive tasks.

SafeBreach offers a breach and attack simulation (BAS) platform that continuously tests security controls by executing real-world attack scenarios to identify vulnerabilities in an organization's defenses. This proactive approach enables businesses to prioritize remediation efforts and effectively manage their cyber risk.

Social Native is a technology platform that automates the sourcing, curation, and management of user-generated content (UGC) and influencer partnerships for e-commerce brands. By streamlining rights management and content activation, it enhances customer engagement and conversion rates while reducing manual processes.